ALKBH3 and lung adenocarcinoma: As generally accepted, cancer cells arrested at G1 phase are much more sensitive to DNA damaging reagents; therefore, ALKBH3 may be one of the key molecules that determine chemotherapeutic efficacy in lung adenocarcinomas.